Jubilant Ingrevia Q4 Revenue Rises 12 Per Cent
ECONOMY & POLICY

Jubilant Ingrevia Q4 Revenue Rises 12 Per Cent

Jubilant Ingrevia reported a healthy performance in Q4 FY26, with revenue rising 12 per cent year-on-year and EBITDA increasing 11 per cent year-on-year. The company said strong execution, resilient demand and effective handling of Middle East disruptions supported its quarterly performance.

The company highlighted that it faced no force majeure and recorded zero production loss during the Middle East crisis. It also achieved successful dispatch from its newly constructed Agro CDMO facility and completed the acquisition of Remidex to accelerate growth in its Human Nutrition business.

The Board recommended a final dividend of Rs 2.50 per share, taking the total FY26 dividend to Rs 5 per share. The company said demand across the chemical industry remains resilient, with volumes growing and pricing firming up due to higher crude-linked costs.

Pharmaceuticals continued to support growth through strong volumes and steady demand, while the agrochemicals business saw strong export visibility and price increases. Nutrition and Personal Care markets also grew, driven by Niacinamide and demand across Feed and Cosmetics.

For FY27, Jubilant Ingrevia expects growth to be led by Specialty Chemicals and Nutrition, supported by recovery in Acetyls. The company also said construction of its Gajraula Multi Purpose Plant is progressing well and will strengthen its CDMO growth roadmap.

Jubilant Ingrevia reported a healthy performance in Q4 FY26, with revenue rising 12 per cent year-on-year and EBITDA increasing 11 per cent year-on-year. The company said strong execution, resilient demand and effective handling of Middle East disruptions supported its quarterly performance.The company highlighted that it faced no force majeure and recorded zero production loss during the Middle East crisis. It also achieved successful dispatch from its newly constructed Agro CDMO facility and completed the acquisition of Remidex to accelerate growth in its Human Nutrition business.The Board recommended a final dividend of Rs 2.50 per share, taking the total FY26 dividend to Rs 5 per share. The company said demand across the chemical industry remains resilient, with volumes growing and pricing firming up due to higher crude-linked costs.Pharmaceuticals continued to support growth through strong volumes and steady demand, while the agrochemicals business saw strong export visibility and price increases. Nutrition and Personal Care markets also grew, driven by Niacinamide and demand across Feed and Cosmetics.For FY27, Jubilant Ingrevia expects growth to be led by Specialty Chemicals and Nutrition, supported by recovery in Acetyls. The company also said construction of its Gajraula Multi Purpose Plant is progressing well and will strengthen its CDMO growth roadmap.

Next Story
Technology

AI-Enabled Workflows Lift Profitability and Productivity

Organisations modernising frontline workflows with artificial intelligence, automation and real-time data are reporting stronger financial performance, higher productivity and improved employee engagement, according to a global study by Zebra Technologies and Oxford Economics.The research covered 1,000 senior leaders across retail, manufacturing, transportation and logistics in the US, Mexico, the UK, Germany, India, Japan, Australia and New Zealand.In transportation and logistics, 54 per cent of companies that improved picking and packing operations reported faster operational performance, wh..

Next Story
Real Estate

India Leads Global AI Readiness but Implementation Lags

Indian companies lead global averages across all eight artificial intelligence readiness indicators tracked by JLL, but only 19 per cent have started making changes to their workplaces, according to the JLL 2026 Future of Work Survey.The study found that 77 per cent of Indian business leaders expect AI to change their office requirements, creating a 58-percentage-point gap between awareness and implementation. The survey covered more than 2,200 CEOs, CFOs and real estate leaders across 21 countries during the first quarter of 2026.Despite concerns over automation, 58 per cent of Indian leaders..

Next Story
Equipment

Three WOLFF Cranes Build Riyadh Cable-Stayed Bridges

Three WOLFF 180 B luffing jib cranes are supporting the construction of two cable-stayed bridges alongside the existing Wadi Laban Bridge in Riyadh, Saudi Arabia. The project is being developed for the Royal Commission for Riyadh City and executed by the ICRC joint venture comprising IC Ictas and Al Rashid Trading & Contracting Company.The cranes are handling lifting operations including formwork, reinforcement, concrete placement, work platforms, surveying equipment and other construction materials. Each crane is fitted with a 40 m jib, reaches a hook height of 157 m and offers a maximum ..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement